跳到主要內容
AI News HubLIVE
來源內容 · 翻譯待補全2 分鐘閱讀

待翻譯:SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity

文章摘要

AI 服務暫時不可用,以下為來源摘要,待恢復後補全翻譯:arXiv:2609.21165v1 Announce Type: new Abstract: Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce specificity optimization (SpecOpt), a molecular design task that seeks constrained structural modifications to an existing compound that increase its binding preference for an intended target over known off-targets while preserving its structural identity and drug-like properties. To enable systematic evaluation, we construct a ChEMBL-derived benchmark from compound-target interaction data, identifying intended targets through curated drug-…

來源arXiv AI作者: Thao Nguyen, Heng Ji
待翻譯:SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity
回報錯誤

更正管道尚未開通,可先複製下方文章資訊留存。

查看更正說明
直接讀正文

AI 服務暫時不可用,以下為來源正文,待恢復後補全翻譯。

[Submitted on 18 Sep 2026] Title:SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity View a PDF of the paper titled SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity, by Thao Nguyen and 1 other authors View PDF HTML (experimental) Abstract:Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design methods focus on generating selective compounds de novo rather than improving the selectivity of existing, well- characterized drugs. We introduce specificity optimization (SpecOpt), a molecular design task that seeks constrained structural modifications to an existing compound that increase its binding preference for an intended target over known off-targets while preserving its structural identity and drug-like properties. To enable systematic evaluation, we construct a ChEMBL-derived benchmark from compound-target interaction data, identifying intended targets through curated drug-mechanism annotations and off- targets through measured activities. We then develop an agentic framework that docks each compound against its intended target and off-targets, compares the resulting poses through residue-aware atom-protein contacts, and provides these differential interactions to a large language model to propose targeted structural modifications. Candidates are retained only if they satisfy molecular similarity, ADMET, and target-off-target docking selectivity criteria. On 915 compounds, the agent improves the target- off-target binding gap for 84.8% of compounds, shifting the mean gap from -0.72 to +0.47 kcal/mol while maintaining a mean Tanimoto similarity of 0.72 to the starting compounds. Ablation studies identify residue-specific contact information as the critical optimization signal: replacing residue identities with binary contact indicators eliminates improvement on all 29 ablation compounds. These results establish SpecOpt as a distinct molecular design problem and demonstrate residue-aware differential interactions as an effective signal for improving the specificity of existing compounds. Subjects: Artificial Intelligence (cs.AI) Cite as: arXiv:2609.21165 [cs.AI] (or arXiv:2609.21165v1 [cs.AI] for this version) https://doi.org/10.48550/arXiv.2609.21165 arXiv-issued DOI via DataCite (pending registration) Submission history From: Thao Nguyen [view email] [v1] Fri, 18 Sep 2026 00:16:35 UTC (703 KB) Full-text links: Access Paper: View a PDF of the paper titled SpecOpt: Contact-Diff Reasoning for Agentic Molecule Optimization Toward Binding Specificity, by Thao Nguyen and 1 other authors View PDF HTML (experimental) TeX Source view license Current browse context: cs.AI new | recent | 2026-09 Change to browse by: cs References & Citations NASA ADS Google Scholar Semantic Scholar Loading... Data provided by: Bibliographic Tools Bibliographic and Citation Tools Bibliographic Explorer Toggle Bibliographic Explorer (What is the Explorer?) Connected Papers Toggle Connected Papers (What is Connected Papers?) Litmaps Toggle Litmaps (What is Litmaps?) scite.ai Toggle scite Smart Citations (What are Smart Citations?) Code, Data, Media Code, Data and Media Associated with this Article alphaXiv Toggle alphaXiv (What is alphaXiv?) Links to Code Toggle CatalyzeX Code Finder for Papers (What is CatalyzeX?) DagsHub Toggle DagsHub (What is DagsHub?) GotitPub Toggle Gotit.pub (What is GotitPub?) Huggingface Toggle Hugging Face (What is Huggingface?) ScienceCast Toggle ScienceCast (What is ScienceCast?) Demos Demos Replicate Toggle Replicate (What is Replicate?) Spaces Toggle Hugging Face Spaces (What is Spaces?) Spaces Toggle TXYZ.AI (What is TXYZ.AI?) Related Papers Recommenders and Search Tools Link to Influence Flower Influence Flower (What are Influence Flowers?) Core recommender toggle CORE Recommender (What is CORE?) Author Venue Institution Topic About arXivLabs arXivLabs: experimental projects with community collaborators arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website. Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them. Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs. Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)

展開要點與分析

文章情報

工程師進階

要點

  • AI 服務暫時不可用,系統已先保留來源內容與降級後設資料。
  • arXiv:2609.21165v1 Announce Type: new Abstract: Off-target protein binding is a major source of adverse effects for small-molecule drugs, yet most structure-based molecular design…

技術影響

可能影響 Agent 架構、工具呼叫、工作流自動化和產品整合。

要點與分析由自動化流程生成,可能有誤,請結合原始來源核實。